Ding Fei, Lai Jindong, Gao Yang, Wang Genhui, Shang Jingwen, Zhang Daojun, Zheng Shumao
Department of Dermatology, Zhoukou Central Hospital, Zhoukou, 466000 Henan China.
Department of Dermatology, Suining First People's Hospital, Suining, 629000 Sichuan China.
Cancer Cell Int. 2019 Aug 22;19:217. doi: 10.1186/s12935-019-0927-6. eCollection 2019.
Melanoma is an extremely aggressive malignant skin tumor with high mortality. Many types of long noncoding RNAs and microRNAs have been reported to be associated with the oncogenesis of melanoma. However, a novel lncRNA-NEAT has not been thoroughly investigated in melanoma cancer. The purposes of this study were to investigate the underlying molecular mechanism in a novel couple of lnc-NEAT1 and miR-23a-3p, as well as the function role of KLF3 in the regulation of melanoma cancer.
28 groups of tumor tissues and normal tissues were obtained from melanoma cancer patients. We performed a series of experiments and analysis, including RT-qPCR, western blots, CCK-8 assay, and migration/invasion assay, to investigate the expressions of NEAT1, miR-23a-5p and KLF3, cell viabilities, and tumor growth in vivo.
In this study, we observed that the expression of NEAT1 was significantly upregulated in melanoma tissues, which remarkedly promoted the cells' proliferation, cell migration, and invasion in melanoma cell lines. Besides, NEAT1 could directly bind to miR-23a-3p, which was found to reverse the effect caused by NEAT1. MiR-23a-3p was discovered to bind to 3'UTR of KLF3, which reduced KLF3 expression. In addition, the overexpression of KLF3 could lower the effects of miR-23a-3p caused on melanoma cancer cell development.
Our results demonstrated that NEAT1 could sponge miR-23a-3p and functions via the expression of KLF3. This axis of NEAT1/miR-23a-5p/KLF3 could together regulate melanoma cancer proliferation. This might provide a new therapeutic strategy for melanoma skin cancer. HBTCM38574839, registered 12 October 2012.
黑色素瘤是一种极具侵袭性的恶性皮肤肿瘤,死亡率很高。据报道,多种长链非编码RNA和微小RNA与黑色素瘤的发生有关。然而,一种新型lncRNA-NEAT在黑色素瘤中尚未得到充分研究。本研究的目的是探讨新型lnc-NEAT1和miR-23a-3p之间潜在的分子机制,以及KLF3在黑色素瘤调控中的作用。
从黑色素瘤患者中获取28组肿瘤组织和正常组织。我们进行了一系列实验和分析,包括RT-qPCR、蛋白质免疫印迹、CCK-8检测和迁移/侵袭检测,以研究NEAT1、miR-23a-5p和KLF3的表达、细胞活力和体内肿瘤生长情况。
在本研究中,我们观察到NEAT1在黑色素瘤组织中的表达显著上调,这明显促进了黑色素瘤细胞系中细胞的增殖、迁移和侵袭。此外,NEAT1可直接与miR-23a-3p结合,而miR-23a-3p可逆转NEAT1所引起的效应。发现miR-23a-3p与KLF3的3'UTR结合,从而降低KLF3的表达。此外,KLF3的过表达可降低miR-23a-3p对黑色素瘤细胞发育的影响。
我们的结果表明,NEAT1可以吸附miR-23a-3p,并通过KLF3的表达发挥作用。NEAT1/miR-23a-5p/KLF3这一轴可共同调节黑色素瘤的增殖。这可能为黑色素瘤皮肤癌提供一种新的治疗策略。HBTCM38574839,2012年10月12日注册。